J. G Barbee
Evid Based Ment Health 2008 11: 77.
web only notes 11/3/77
Notes
Participants were receiving a variety of different antidepressant monotherapies which were augmented with risperidone; this limits the meaningfulness of comparisons that can be made between particular risperidone-antidepressant combinations. Intention-to-treat analyses were carried out using mixed model repeated measures ANCOVA based on observed data. In the risperidone group, 19% of participants discontinued treatment compared with 12% in the placebo group.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
